People: Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

11 Oct 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Klencke, Barbara 

Dr. Barbara Klencke, M.D. serves as Chief Development Officer of the company., Since June 2015. Previously, Dr. Klencke served as the Senior Vice President, Development at Onyx Pharmaceuticals, a biopharmaceutical company and a subsidiary of Amgen Inc., from January 2011 to June 2015, and as the Group Medical Director in Product Development, Oncology at Genentech, Inc., a biotechnology company, from July 2003 to January 2011. Prior to that, Dr. Klencke served as the Medical Director at Chiron Corporation, a biotechnology company later acquired by Novartis International AG, and as an assistant professor of medicine at the University of California, San Francisco Medical Center. Dr. Klencke holds a B.S. from Indiana University and an M.D. from the University of California, Davis.

Basic Compensation

Total Annual Compensation, USD 1,361,160
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 127,600
Fiscal Year Total, USD 1,488,760

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --